Related references
Note: Only part of the references are listed.Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
George K. Siberry et al.
CLINICAL INFECTIOUS DISEASES (2015)
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus
Huey-Ling Chen et al.
HEPATOLOGY (2015)
Telbivudine During the Second and Third Trimester of Pregnancy Interrupts HBV Intrauterine Transmission: A Systematic Review and Meta-analysis
Yong-Ping Lu et al.
CLINICAL LABORATORY (2014)
Telbivudine or Lamivudine Use in Late Pregnancy Safely Reduces Perinatal Transmission of Hepatitis B Virus in Real-Life Practice
Hua Zhang et al.
HEPATOLOGY (2014)
How to Read a Systematic Review and Meta-analysis and Apply the Results to Patient Care Users' Guides to the Medical Literature
Mohammad Hassan Murad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus
Min-Min Yu et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus
Astrid-Jane Greenup et al.
JOURNAL OF HEPATOLOGY (2014)
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection
Mustafa Kemal Celen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants
George K. Siberry et al.
AIDS (2012)
Telbivudine Prevents Vertical Transmission From HBeAg-Positive Women With Chronic Hepatitis B
Calvin Q. Pan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus
M. Yu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: Findings from the Antiretroviral Pregnancy Registry
Robert S. Brown et al.
JOURNAL OF HEPATOLOGY (2012)
Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers
H. Zou et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B
Eugene R. Schiff et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection
Guo-Rong Han et al.
JOURNAL OF HEPATOLOGY (2011)
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus
Lei Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus A Systematic Review and Meta-Analysis
Zhongjie Shi et al.
OBSTETRICS AND GYNECOLOGY (2010)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study
W. -M. Xu et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F
Stephen E. Livingston et al.
GASTROENTEROLOGY (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Interruption of HBV intrauterine transmission: A clinical study
XM Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Share Paper
